Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study for the Dual Orexin Receptor Antagonist Lemborexant in Improving Motor-Sleep Comorbidity in Parkinson's Disease

NCT07384429 is registered in ClinicalTrials.gov with YangPan as lead sponsor.

NCT NCT07384429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07384429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study for the Dual Orexin Receptor Antagonist Lemborexant in Improving Motor-Sleep Comorbidity in Parkinson's Disease
Lead sponsor
YangPan
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 19, 2026
Completion date
December 1, 2026
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, motor disorder, parkinson's disease